TREA

97261958 - BIOTRILLION

Follow

Information

  • Trademark
  • 97261958
  • Serial Number
    97261958
  • Filing Date
    February 10, 2022
    3 years ago
  • Transaction Date
    February 02, 2025
    a month ago
  • Status Date
    February 02, 2025
    a month ago
  • Published for Opposition Date
    September 05, 2023
    a year ago
  • Location Date
    February 02, 2025
    a month ago
  • First Use Anywhere Date
    January 01, 2018
    7 years ago
  • First Use In Commerce Date
    June 05, 2024
    9 months ago
  • Status Code
    807
  • Current Location
    TMEG LAW OFFICE 101
    Employee Name
    PEREZ, STEVEN
  • Attorney Docket Number
    552674.16
    Attorney Name
    Caroline Chicoine
    Law Office Assigned Location Code
    L10
  • Owners
Information
Mark Drawing Code
4
Mark Identification
BIOTRILLION
Case File Statements
  • GS0091: downloadable computer software platforms for measuring and processing digital biomarkers to aid in the prevention, detection, or intervention of diseases, disorders, drug effects, or drug use; Downloadable computer software platforms for use in the prevention, detection, or intervention of diseases, disorders, or drugs, namely, for use to aid in digitally measuring the physiologic signs of diseases, disorders, drug effects, or drug use; downloadable computer software platforms for use in the prevention, detection, or intervention of diseases, disorders, or drugs, namely, for use and aid in digitally collecting physiological data; Downloadable computer software platforms for use to aid in digitally measuring the physiologic signs of diseases, disorders, drug effects, or drug use; downloadable software for use in the prevention, detection, or intervention of diseases, disorders, or drugs, namely, for use to aid in digitally measuring the physiologic signs of diseases, disorders, drug effects or drug use; downloadable software for measuring and processing digital biomarkers to aid in the detection of diseases, disorders, drug effects, or drug use; downloadable software for use to aid in digitally measuring the physiologic signs of diseases, disorders, drug effects or drug use; downloadable software for use in the prevention, detection, or intervention of diseases, disorders, or drugs, namely, for use and aid in digitally collecting physiologic data; downloadable software for measuring and processing digital biomarkers to aid in the detection of diseases, disorders, drug effects, or drug use; Downloadable software for use and aid in digitally collecting physiologic data of diseases, disorders, or drug effects or drug use; downloadable mobile applications for use in the prevention, detection, or intervention of diseases, disorders, or drugs, namely, for use to aid in digitally measuring the physiologic signs of diseases, disorders, drug effects or drug use; Downloadable mobile applications for measuring and processing digital biomarkers to aid in the detection of diseases, disorders, drug effects, or drug use; downloadable mobile applications for use to aid in digitally measuring the physiologic signs of diseases, disorders, drug effects, or drug use; downloadable mobile applications for measuring and processing digital biomarkers to aid in the detection of diseases, disorders, drug effects, or drug use; downloadable mobile applications for use in the prevention, detection, or intervention of diseases, disorders, or drugs, namely, for use and aid in digitally collecting physiologic data
  • GS0421: Software as a service (SAAS) services featuring software for use in the prevention, detection, or intervention of diseases, disorders, or drugs, namely, for use to aid in digitally measuring the physiologic signs of diseases, disorders, drug effects or drug use; software as a service (SAAS) services featuring software for measuring and processing digital biomarkers to aid in the prevention, detection, or intervention of diseases, disorders, drug effects, or drug use; software as a service (SAAS) services featuring software for use to aid in digitally measuring the physiologic signs of diseases, disorders, drug effects or drug use; software as a service (SAAS) services featuring software for use in the prevention, detection, or intervention of diseases, disorders, or drugs, namely, for use and aid in digitally collecting physiologic data; software as a service (SAAS) services featuring downloadable software for use and aid in digitally collecting physiologic data of diseases, disorders, drug effects or drug use
Case File Event Statements
  • 2/14/2022 - 3 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 2/15/2022 - 3 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 11/23/2022 - 2 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 12/5/2022 - 2 years ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 12/5/2022 - 2 years ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 12/5/2022 - 2 years ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 3/6/2023 - 2 years ago
    7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 3/6/2023 - 2 years ago
    8 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 3/6/2023 - 2 years ago
    9 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 4/6/2023 - a year ago
    10 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 4/6/2023 - a year ago
    11 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 4/6/2023 - a year ago
    12 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 7/3/2023 - a year ago
    13 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 7/3/2023 - a year ago
    14 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 7/4/2023 - a year ago
    15 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 7/29/2023 - a year ago
    16 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 8/16/2023 - a year ago
    17 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 9/5/2023 - a year ago
    18 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 9/5/2023 - a year ago
    19 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 10/31/2023 - a year ago
    20 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 4/15/2024 - 11 months ago
    21 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 4/15/2024 - 11 months ago
    22 - SOU EXTENSION 1 FILED Type: EXT1
  • 4/15/2024 - 11 months ago
    23 - SOU EXTENSION 1 GRANTED Type: EX1G
  • 10/29/2024 - 5 months ago
    27 - USE AMENDMENT FILED Type: IUAF
  • 4/16/2024 - 11 months ago
    24 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 10/29/2024 - 5 months ago
    25 - TEAS STATEMENT OF USE RECEIVED Type: EISU
  • 1/15/2025 - 2 months ago
    28 - STATEMENT OF USE PROCESSING COMPLETE Type: SUPC
  • 1/15/2025 - 2 months ago
    26 - CASE ASSIGNED TO INTENT TO USE PARALEGAL Type: AITU
  • 2/2/2025 - a month ago
    29 - SU - NON-FINAL ACTION - WRITTEN Type: CNRT
  • 2/2/2025 - a month ago
    30 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 2/2/2025 - a month ago
    31 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN